Folic acid therapy in the fragile X syndrome.

Treatments for fragile X syndrome: a closer look at the data. Dev Disabil Res Rev (2009) 0.91

Systematic review of pharmacological treatments in fragile X syndrome. BMC Neurol (2009) 0.80

Folic acid blinded trial in identical twins with fragile X syndrome. Am J Hum Genet (1985) 0.79

A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial. Trials (2014) 0.77

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell (1999) 12.50

Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med (1991) 7.17

A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell (1996) 5.97

Predicting coiled coils by use of pairwise residue correlations. Proc Natl Acad Sci U S A (1995) 5.94

The effect of metallic salts on the glycolysis and respiration of tissues. Biochem J (1928) 5.87

An investigation into the numbers of dentists from 19 European Economic Area (EEA) member states currently registered to work in the United Kingdom and key differences between the practise of dentistry in the UK and their member states of origin. Br Dent J (2011) 5.57

Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med (1991) 5.30

Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A (1995) 5.25

Australia develops national strategy for bringing physicians to rural areas. CMAJ (1994) 4.61

Specific Constants for Visual Excitation. Proc Natl Acad Sci U S A (1937) 4.60

Identifying complications of care using administrative data. Med Care (1994) 4.01

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med (1998) 3.95

Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92

A computationally directed screen identifying interacting coiled coils from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2000) 3.92

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer (1981) 3.86

Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82

RNA polymerase III transcriptional units are interspersed among human non-alpha-globin genes. Proc Natl Acad Sci U S A (1979) 3.78

Stomach NO synthesis. Nature (1994) 3.70

Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science (1968) 3.69

Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc Natl Acad Sci U S A (2001) 3.25

The heart of the matter: Dalton Camp and his controversial transplant. CMAJ (1993) 3.21

Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell (1992) 3.20

Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17

A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol (1997) 3.11

Can the uptake of breast screening by Asian women be increased? A randomized controlled trial of a linkworker intervention. J Public Health Med (1994) 3.04

Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00

Athletic activity in adolescence as an etiological factor in degenerative hip disease. J Bone Joint Surg Br (1971) 2.89

The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem (2001) 2.89

Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85

Relation between parasuicide, suicide, psychiatric admissions, and socioeconomic deprivation. BMJ (1995) 2.83

Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet (1991) 2.70

Lawyers out of hospitals, doctors out of court. Ann R Coll Surg Engl (1998) 2.69

Managed care: devils, angels, and the truth in between. Health Prog (1999) 2.68

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ (1998) 2.61

Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA (1993) 2.59

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57

Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol (1974) 2.51

Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet (1987) 2.44

Pigmentary epitheliopathy and erythema nodosum. Arch Ophthalmol (1971) 2.39

Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38

A complex mutable polymorphism located within the fragile X gene. Nat Genet (1993) 2.33

Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30

On the Duplexity Theory of Visual Response in Vertebrates. Proc Natl Acad Sci U S A (1938) 2.22

Disruption of the CNTF gene results in motor neuron degeneration. Nature (1993) 2.22

Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology (2008) 2.12

Detection and surveillance of colorectal cancer. JAMA (1989) 2.07

Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program. Ann Intern Med (1989) 2.07

Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. JPEN J Parenter Enteral Nutr (1990) 2.06

Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes. Diabetes (1982) 2.05

Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors. Ann Intern Med (1999) 2.05

The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia (1983) 2.04

T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med (1994) 2.04

Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J Virol (1996) 1.98

Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol (1996) 1.96

Case report. Metastatic pulmonary calcification in renal failure: a new HRCT pattern. Br J Radiol (2002) 1.95

The International Collaborative Study of Maternal Phenylketonuria: status report 1998. Eur J Pediatr (2000) 1.91

Chemical structure of the exine of pollen walls and a new function for carotenoids in nature. Nature (1968) 1.91

Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res (2000) 1.90

High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer. JAMA (1996) 1.90

Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect Immun (1989) 1.86

Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A (1990) 1.82

Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (1985) 1.80

Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer (2007) 1.77

The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77

What price survival? The future of Blue Cross and Blue Shield. JAMA (1998) 1.75

Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet (2004) 1.73

A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet (1997) 1.71

Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet (1997) 1.70

Characterization of a mutation in the lens-specific MP70 encoding gene of the mouse leading to a dominant cataract. Exp Eye Res (2001) 1.69

The biogenetic anatomy of vitamin B6. A 13C NMR investigation of the biosynthesis of pyridoxol in Escherichia coli. J Biol Chem (1996) 1.68

Primary prevention of diabetes mellitus. Diabetes Care (1987) 1.67

A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol (1987) 1.65

The uninsured. From dilemma to crisis. JAMA (1991) 1.65

Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab (1996) 1.65

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med (1996) 1.65

Slicing the pie thinner: hospitals and physicians square off over primary care services. Hospitals (1982) 1.64

Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest (1992) 1.64

The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol (2000) 1.63

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS (2001) 1.63

Impaired learning in mice with abnormal short-lived plasticity. Curr Biol (1996) 1.63

Epidemiology and patterns of hospital use after parasuicide in the south west of England. J Epidemiol Community Health (1996) 1.62

Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet (1995) 1.61

Prediction of early course of breast carcinoma by thymidine labeling. Cancer (1983) 1.61

Coping with calamity. How well does health care disaster planning work? JAMA (1994) 1.61

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60

Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res (2001) 1.60

Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol (2002) 1.60

DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. Proc Natl Acad Sci U S A (1997) 1.58

Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med (1982) 1.58

Patterns in costs and outcomes for patients with prolonged mechanical ventilation undergoing tracheostomy: an analysis of discharges under diagnosis-related group 483 in New York State from 1992 to 1996. Crit Care Med (1999) 1.58

Fragile X and autism: a multicenter survey. Am J Med Genet (1986) 1.56

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology (2012) 1.56

Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation (2001) 1.56

Detection of full fragile X mutation. Lancet (1992) 1.55

Malignant fibrous histiocytoma: an institutional review. Cancer Invest (2001) 1.54